The human T-cell leukemia virus type 1 (HTLV-1), identified as the first human oncogenic
retrovirus 30 years ago, is not an ubiquitous virus. HTLV-1 is present throughout the world …

It is 30 years since human T-cell leukemia virus type 1 (HTLV-1) was identified as the first
human retrovirus. To assess the implications of the virus for human health it is very important …

It has been nearly 40 years since human T-cell leukemia virus-1 (HTLV-1), the first
oncogenic retrovirus in humans and the first demonstrable cause of cancer by an infectious …

Adult T-cell leukemia-lymphoma (ATL) is an aggressive T-cell malignancy caused by human
T-cell leukemia virus type 1 (HTLV-1) infection that often occurs in HTLV-1-endemic areas …

Human T cell leukemia virus (HTLV-1) is an oncoretrovirus that infects at least 10 million
people worldwide. HTLV-1 exhibits a remarkable genetic stability, however, viral strains …

Human T cell leukemia virus type 1 (HTLV-1) was the first discovered human retrovirus and
the etiologic agent of adult T-cell leukemia and HTLV-1-associated myelopathy/tropical …

The African continent is considered the largest high endemic area for the oncogenic
retrovirus HTLV-1 with an estimated two to five million infected individuals. However, data on …

To gain new insights on the origin, evolution, and modes of dissemination of human T-cell
leukemia virus type I (HTLV-1), we performed a molecular analysis of 58 new African HTLV …

ABSTRACT The Human T-Lymphotropic Virus type 1 (HTLV-1) affects up to 10 million
people worldwide. It is directly associated to one of the most aggressive T cell malignancies …

Human T cell leukemia/lymphoma virus Type 1 and 2 (HTLV-1 and HTLV-2), together with
their simian counterparts (STLV-1, STLV-2), belong to the Primate T lymphotropic viruses …